Suïcidepoging tijdens elektroconvulsietherapie bij een adolescente met een bipolaire stemmingsstoornis

2021 ◽  
Author(s):  
I.C.S.I. TJIA ◽  
N. VANDERBRUGGEN ◽  
A. LAMPO ◽  
S.L.B. BONDUELLE
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Case Report ◽  
Suicidal Ideation ◽  
Literature Review ◽  
Electroconvulsive Therapy ◽  
Bipolar Depression ◽  
Manic Episode ◽  
Female Adolescent ◽  
Major Depressive

Suicide attempt during electroconvulsive therapy by a female adolescent with bipolar disorder Electroconvulsive therapy (ECT) is an effective treatment for certain psychiatric disorders, including a major depressive disorder, an acute manic episode, bipolar depression, schizophrenia and catatonia in adults. ECT is less often prescribed for adolescents compared to adults. Many child and adolescent psychiatrists indicate that they do not have enough knowledge or experience to prescribe or provide ECT. By means of a case report and literature review, different variables to take into account when administering ECT to adolescents with a mood disorder are described. The case report emphasizes the importance of continued alertness for suicidal ideation during ECT.

scholarly journals Mechanism of action of cariprazine

CNS Spectrums ◽  
2016 ◽  
Vol 21 (2) ◽  
pp. 123-127 ◽  
Author(s):  
Stephen M. Stahl
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Mechanism Of Action ◽  
Therapeutic Agent ◽  
Bipolar Depression ◽  
Major Depressive

Cariprazine is a new therapeutic agent recently approved for the treatment of both schizophrenia and manic or mixed episodes associated with bipolar disorder, and is under investigation for the treatment of both bipolar depression and major depressive disorder.

A Patient With Electroconvulsive Therapy–resistant Major Depressive Disorder With a Full Response to Heated Yoga: A Case Report

2021 ◽  
Vol 27 (6) ◽  
pp. 486-491
Author(s):  
Hitoshi Sakurai ◽  
Richard J. Norton ◽  
Lauren B. Fisher ◽  
Megha V. Nagaswami ◽  
Chris C. Streeter ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Case Report ◽  
Depressive Disorder ◽  
Electroconvulsive Therapy ◽  
Major Depressive

Place of electroconvulsive therapy in the treatment of depression in France: A comparative study between clinical practice and international recommendations

2017 ◽  
Vol 41 (S1) ◽  
pp. S767-S768
Author(s):  
T. Charpeaud ◽  
A. Tremey ◽  
P. Courtet ◽  
B. Aouizerate ◽  
P.M. Llorca
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Electroconvulsive Therapy ◽  
Bipolar Depression ◽  
Psychotic Symptoms ◽  
Diagnosis Delay ◽  
Recurrent Depression ◽  
University Hospitals ◽  
Major Depressive ◽  
Competing Interest

ObjectivesTo study the place of electroconvulsive therapy (ECT) in the treatment of major depressive disorder in France and compare it with international recommendations and algorithms.MethodMulticenter, retrospective study in 12 French university hospitals. Diagnosis, delay between the onset of the episode and the first day of ECT, previous treatments have been identified. Only patients treated for major depressive disorder between 1 January 2009 and 1 January 2014 were included.ResultsA total of 754 patients were included (middle age 61.07 years, sex ratio 0.53). The diagnoses listed were: first major depressive episode (14.95%), bipolar depression (38.85%) and unipolar recurrent depression (46.19%). The delay before ECT, was 11.01 months (13,98), and was significantly longer for first episodes (16.45 months, P < 0.001) and shorter in case of psychotic symptoms (8.76 months, P < 0.03) and catatonic symptoms (6.70, P < 0.01).ConclusionsThe delay before ECT appears on average, four times longer than recommended by treatment algorithms for the management of major depressive disorder. This long delay could be explained by a very heterogeneous access to this treatment in French territory.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees

2011 ◽  
Vol 199 (4) ◽  
pp. 303-309 ◽  
Author(s):  
Philip B. Mitchell ◽  
Andrew Frankland ◽  
Dusan Hadzi-Pavlovic ◽  
Gloria Roberts ◽  
Justine Corry ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Clinical Features ◽  
Bipolar Depression ◽  
Bipolar Affective Disorder ◽  
Probabilistic Approach ◽  
Psychomotor Retardation ◽  
Major Depressive ◽  
Depressive Episodes

BackgroundAlthough genetic epidemiological studies have confirmed increased rates of major depressive disorder among the relatives of people with bipolar affective disorder, no report has compared the clinical characteristics of depression between these two groups.AimsTo compare clinical features of depressive episodes across participants with major depressive disorder and bipolar disorder from within bipolar disorder pedigrees, and assess the utility of a recently proposed probabilistic approach to distinguishing bipolar from unipolar depression. A secondary aim was to identify subgroups within the relatives with major depression potentially indicative of ‘genetic’ and ‘sporadic’ subgroups.MethodPatients with bipolar disorder types 1 and 2 (n = 246) and patients with major depressive disorder from bipolar pedigrees (n = 120) were assessed using the Diagnostic Interview for Genetic Studies. Logistic regression was used to identify distinguishing clinical features and assess the utility of the probabilistic approach. Hierarchical cluster analysis was used to identify subgroups within the major depressive disorder sample.ResultsBipolar depression was characterised by significantly higher rates of psychomotor retardation, difficulty thinking, early morning awakening, morning worsening and psychotic features. Depending on the threshold employed, the probabilistic approach yielded a positive predictive value ranging from 74% to 82%. Two clusters within the major depressive disorder sample were found, one of which demonstrated features characteristic of bipolar depression, suggesting a possible ‘genetic’ subgroup.ConclusionsA number of previously identified clinical differences between unipolar and bipolar depression were confirmed among participants from within bipolar disorder pedigrees. Preliminary validation of the probabilistic approach in differentiating between unipolar and bipolar depression is consistent with dimensional distinctions between the two disorders and offers clinical utility in identifying patients who may warrant further assessment for bipolarity. The major depressive disorder clusters potentially reflect genetic and sporadic subgroups which, if replicated independently, might enable an improved phenotypic definition of underlying bipolarity in genetic analyses.

scholarly journals Individuals with bipolar disorder have a higher level of peripheral uric acid than major depressive disorder: a case-control study

2021 ◽  
Author(s):  
Zhe Lu ◽  
Yingtan Wang ◽  
Guanglei Xun
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Case Control Study ◽  
Bipolar Depression ◽  
Unipolar Depression ◽  
Acute Stage ◽  
Major Depressive ◽  
Drug Free ◽  
Control Study

Abstract Background: At present, no well-established biomarkers were ever found to distinguish unipolar depression (UD) and bipolar disorder (BD). This study aimed to provide a clearer comparison of UA levels between BD and major depressive disorder. Methods: Peripheral UA of 119 patients with BD in acute stage (AS) and 77 in remission stage (RS), and 95 patients with UD in AS and 61 in RS were measured, so were 180 healthy controls. Results: UA levels in BD group were higher than UD and HC groups regardless of the AS or RS, while differences in UA levels between UD group and HC group were not significant. Differences in UA levels of BD-M (bipolar mania/hypomania) were higher than BD-D (bipolar depression) subgroups, and UA levels of BD-M and BD-D subgroups were higher than UD and HC groups. The comparison of number of participants with hyperuricemia among groups confirmed the above results. There were no significant differences in UA levels of between drug-use and drug-free/naïve subgroups. Conclusion: The study suggests patients with BD had a higher level of UA than UD, especially in mania episode.

scholarly journals Homicide attempt due to medication induced mania

2021 ◽  
Author(s):  
Jordan Berry ◽  
Naghmeh Mokhber ◽  
Arun Prakash ◽  
Ajay Prakash ◽  
Julie Zamprogna
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Depressive Symptoms ◽  
Mental Disorders ◽  
Bipolar Depression ◽  
Bipolar Disorders ◽  
Depressive State ◽  
Major Depressive ◽  
Difficult Situation ◽  
Serotonergic Antidepressant

Bipolar disorders are a group of mental disorders characterized by fluctuations in mood, with depressive symptoms generally dominating the course of disorder. Research on the efficacy of serotonergic antidepressants in bipolar depression is controversial and as a result, treatment of depressive symptoms in bipolar disorder is difficult. A particularly difficult situation arises when bipolar disorder is unrecognized and the depressive state is treated as major depressive disorder with the use of serotonergic antidepressants, which can result in the phenomenon of antidepressant induced mania (AIM). In this report, we present a case of antidepressant induced mania (AIM) with homicidal ideation after initiation of serotonergic antidepressants. Here, we discuss the importance of monitoring for bipolar disorder after prescribing serotonergic antidepressant therapy as well as medico-legal considerations.

Mood (Affective) Disorders

2018 ◽  
pp. 15-60
Author(s):  
Carol S. North ◽  
Sean H. Yutzy
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Mood Disorders ◽  
Affective Disorders ◽  
Essential Feature ◽  
Severe Depression ◽  
Manic Episode ◽  
Major Depressive ◽  
Manic Symptoms ◽  
Mood Depression

Descriptions of mood disorders go back to the time of Hippocrates. Mood disorders are primarily characterized by depressed and/or elevated (manic) moods. The essential feature of mood disorders is an episode that is a distinct and persistent change from a person’s typical mood (depression or mania), accompanied by other depressive and manic symptoms, lasting 2 weeks for a major depressive episode and 1 week for a manic episode. Such episodes typically remit and recur over the course of time. Manic episodes define bipolar disorder. Severe depression without manic episodes is diagnosed as major depressive disorder. Mood disorders present a 10- to 30-fold risk for suicide. Effective treatments for mood disorders include medications, brain stimulation modalities, and psychotherapy.

Sign in / Sign up

Export Citation Format

Share Document